左旋多巴治疗帕金森病的精神方面问题。
Psychiatric aspects in Parkinsonism treated with L-dopa.
作者信息
Damãsio A R, Lobo-Antunes J, Macedo C
出版信息
J Neurol Neurosurg Psychiatry. 1971 Oct;34(5):502-7. doi: 10.1136/jnnp.34.5.502.
Abstract
Psychiatric aspects of patients with Parkinsonism treated with L-dopa are described. These include acute psychosis in patients with or without previous psychiatric illness and worsening or improvement of pre-existing psychiatric conditions. Therapeutic management is discussed The relevance of these studies to the understanding of the psychiatric aspects of Parkinsonism in general is discussed.
摘要
描述了用左旋多巴治疗的帕金森病患者的精神方面问题。这些问题包括有或无既往精神疾病患者的急性精神病，以及既往存在的精神状况的恶化或改善。讨论了治疗管理。还讨论了这些研究对总体理解帕金森病精神方面问题的相关性。
相似文献
1
Psychiatric aspects in Parkinsonism treated with L-dopa.左旋多巴治疗帕金森病的精神方面问题。
J Neurol Neurosurg Psychiatry. 1971 Oct;34(5):502-7. doi: 10.1136/jnnp.34.5.502.
2
[Case reports of some mental disorders in parkinsonian patients treated with L-dopa].[左旋多巴治疗帕金森病患者中一些精神障碍的病例报告]
Minerva Med. 1974 Feb 3;65(8):398-401.
3
L-dopa for parkinsonism.用于帕金森病的左旋多巴。
Geriatrics. 1973 Jan;28(1):86-8.
4
[Psychiatric complications of L-Dopa treatment of parkinsonism].
Tidsskr Nor Laegeforen. 1973 Apr 10;93(10):680-5.
5
L-dopa in the treatment of parkinsonism.左旋多巴治疗帕金森病。
Gerontol Clin (Basel). 1972;14(4):242-8. doi: 10.1159/000245399.
6
[Treatment of Parkinson's syndrome with L-dopa].[左旋多巴治疗帕金森综合征]
Schweiz Med Wochenschr. 1970 May 9;100(19):805-13.
7
Psychosis and other psychiatric manifestations of levodopa therapy.左旋多巴治疗的精神病及其他精神科表现。
Arch Neurol. 1970 Sep;23(3):193-200. doi: 10.1001/archneur.1970.00480270003001.
8
Behavioral effects of l-dopa in man.左旋多巴对人体的行为影响。
Semin Psychiatry. 1971 Nov;3(4):477-92.
9
Mental symptoms in Parkinsonian patients treated with L-dopa.
Lancet. 1970 Jul 25;2(7665):177-9. doi: 10.1016/s0140-6736(70)92535-3.
10
L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects.帕金森病的左旋多巴治疗：血浆左旋多巴浓度、治疗反应及副作用。
Mayo Clin Proc. 1971 Apr;46(4):231-9.
引用本文的文献
1
Parkinson disease psychosis: from phenomenology to neurobiological mechanisms.帕金森病精神病：从现象学到神经生物学机制。
Nat Rev Neurol. 2024 Mar;20(3):135-150. doi: 10.1038/s41582-023-00918-8. Epub 2024 Jan 15.
2
The effects of anxiety and external attentional focus on postural control in patients with Parkinson's disease.焦虑和外部注意力焦点对帕金森病患者姿势控制的影响。
PLoS One. 2018 Feb 1;13(2):e0192168. doi: 10.1371/journal.pone.0192168. eCollection 2018.
3
Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.帕金森病中的精神病与并发的冲动控制障碍：基于病例报告的综述
Dement Neuropsychol. 2016 Apr-Jun;10(2):148-151. doi: 10.1590/S1980-5764-2016DN1002011.
4
Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the Gene, a Risk Factor for Parkinson's Disease.司来吉兰改善缺乏帕金森病风险因素基因的小鼠的抑郁样行为。
Front Behav Neurosci. 2017 May 3;11:75. doi: 10.3389/fnbeh.2017.00075. eCollection 2017.
5
Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA.多巴胺前体L-多巴对血清素突触传递的抑制作用。
Cell Rep. 2015 Aug 11;12(6):944-54. doi: 10.1016/j.celrep.2015.07.005. Epub 2015 Jul 30.
6
Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update.帕金森病患者的适应性奖励学习和冲动控制障碍：临床概述和病理生理学更新。
J Mov Disord. 2014 Oct;7(2):67-76. doi: 10.14802/jmd.14010. Epub 2014 Oct 30.
7
Does anxiety cause freezing of gait in Parkinson's disease?焦虑会导致帕金森病患者步态冻结吗？
PLoS One. 2014 Sep 24;9(9):e106561. doi: 10.1371/journal.pone.0106561. eCollection 2014.
8
A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.帕金森病非运动症状的小鼠模型：聚焦于针对情感功能障碍的药物干预。
Front Behav Neurosci. 2014 Aug 27;8:290. doi: 10.3389/fnbeh.2014.00290. eCollection 2014.
9
Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus.长期使用左旋多巴会减少中缝背核一个亚区域中的5-羟色胺能神经元。
J Pharmacol Exp Ther. 2014 Nov;351(2):440-7. doi: 10.1124/jpet.114.218966. Epub 2014 Sep 11.
10
Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.帕金森病患者冲动控制和重复行为障碍的临床特征。
J Neurol. 2013 Feb;260(2):429-37. doi: 10.1007/s00415-012-6645-9. Epub 2012 Aug 15.
本文引用的文献
1
Cognitive function in Parkinson's disease.帕金森病中的认知功能
J Nerv Ment Dis. 1962 Sep;135:196-205.
2
Parkinsonism: onset, progression and mortality.帕金森症：发病、进展与死亡率
Neurology. 1967 May;17(5):427-42. doi: 10.1212/wnl.17.5.427.
3
Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease.
Psychiatr Neurol (Basel). 1965;150(6):345-57. doi: 10.1159/000127780.
4
Treatment of parkinsonism with levodopa.左旋多巴治疗帕金森症。
Arch Neurol. 1969 Oct;21(4):343-54. doi: 10.1001/archneur.1969.00480160015001.
5
Critical analysis of the disability in Parkinson's disease.帕金森病残疾状况的批判性分析。
Mod Treat. 1968 Mar;5(2):257-82.
6
7
Psychosis and other psychiatric manifestations of levodopa therapy.左旋多巴治疗的精神病及其他精神科表现。
Arch Neurol. 1970 Sep;23(3):193-200. doi: 10.1001/archneur.1970.00480270003001.
8
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).用左旋多巴治疗帕金森综合征。
Ann Intern Med. 1970 Jan;72(1):29-35. doi: 10.7326/0003-4819-72-1-29.
9
Stereotyped activities produced by amphetamine in several animal species and man.安非他命在多种动物和人类身上引发的刻板行为。
Psychopharmacologia. 1967;11(4):300-10. doi: 10.1007/BF00404607.
10
L-dopa plus decarboxylase inhibitor in depression.
Lancet. 1970 Sep 26;2(7674):660-1. doi: 10.1016/s0140-6736(70)91425-x.
Zotero 插件